Gusperimus
- Generic Name
- Gusperimus
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H37N7O3
- CAS Number
- 98629-43-7
- Unique Ingredient Identifier
- UJ0ZJ76DO9
- Background
Gusperimus has been used in trials studying the treatment of Lupus Nephritis, Wegeners Granulomatosis, and Wegener's Granulomatosis.
- Indication
短期经静脉给药用于肾移植的急性排异反应，与皮质激素或环孢素合用可增效。也可用于各种自身免疫性疾病，对风湿性关节炎、全身性红斑狼疮、肾小球肾炎有一定疗效。
- Associated Conditions
- -
- Associated Therapies
- -
Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis
- First Posted Date
- 2007-09-17
- Last Posted Date
- 2017-03-06
- Lead Sponsor
- Nippon Kayaku Co., Ltd.
- Target Recruit Count
- 45
- Registration Number
- NCT00530075
- Locations
- 🇸🇪
Karolinska University Hospital, Stockholm, Sweden
🇳🇱University Hospital Maastricht, Maastricht, Netherlands
🇬🇧Addenbrookes Hospital, Cambridge, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath